Cite Filings / ACRV / 9999999997-22-004721

Feed Companies Filings Check

Sign in

SEC STAFF LETTER

SEC Staff Letter Redacted Exhibit

Acrivon Therapeutics, Inc. Filed 2022-11-09 Acc 9999999997-22-004721

Documents 1

SEC STAFF LETTER SEC Staff Letter Redacted Exhibit , filename1.pdf

Around this filing

2022-11-09 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2022-11-09 EFFECT Notice of Effectiveness
2022-11-09 3 Initial Statement of Ownership
2022-11-09 3 Initial Statement of Ownership
2022-11-09 3 Initial Statement of Ownership
2022-11-09 3 Initial Statement of Ownership
2022-09-14 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading filename1.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…